We previously reported that despite receiving more enteral and IV iron supplementation, more Epo- than placebo-treated infants had evidence of moderate or severe iron deficiency during their hospitalization, potentially contributing to oligodendrocyte injury and white matter structural changes as seen by DTI [4,79]. Here, EPO is linked to Iron deficiency anemia.